Araujo, D., Greystoke, A., Bates, S., Bayle, A., Calvo, E., Castelo-Branco, L., de Bono, J., Drilon, A., Garralda, E., Ivy, P., Kholmanskikh, O., Melero, I., Pentheroudakis, G., Petrie, J., Plummer, R., Ponce, S., Postel-Vinay, S., Siu, L., Spreafico, A., … Seymour, L. (2023). Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Annals of Oncology, 34(1), 48–60. https://doi.org/10.1016/j.annonc.2022.09.158
Subjects:
Antineoplastic Agents
(MeSH)
Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2022.09.158
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: